123 results
8-K
EX-99.1
LUMO
Lumos Pharma Inc
15 Nov 23
Other Events
4:38pm
childhood Majority of cases are moderate Slower physical growth Negative effect on metabolic processes Incidence ≈ 1:35001 Injectable therapies are only … Preference Vast majority of physicians & caregivers surveyed prefer daily oral tablet over weekly injectable MOA Favorable impression regarding LUM-201
8-K
EX-99.1
LUMO
Lumos Pharma Inc
21 Jun 23
Lumos to Highlight New LUM-201 Data and Analysis Presented
5:10pm
an opportunity for moderate idiopathic PGHD patients – the majority of the total PGHD population1 – to
avoid the daily or weekly injections involved
8-K
EX-99.2
LUMO
Lumos Pharma Inc
14 Nov 22
Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency
6:55am
; Less frequent administration of injectable therapy Preference Vast majority of physicians & caregivers surveyed prefer daily oral tablet over weekly … to 2026 2 Rosenfeld 2008 Endocrine Practice 3 Cutfield 2011 PLOS ONE Inadequate secretion of growth hormone during childhood Majority of cases
424B5
8rkkpf6as6p j1ke
29 Aug 22
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
mjui3armc9lpm6urvqxn
3 Nov 21
Lumos Pharma Reports Third Quarter 2021 Financial Results and Provides Clinical Updates
4:11pm
8-K
EX-99.1
3ipb9h6a3kzmo0zn
23 Aug 21
Other Events
4:43pm
8-K
EX-99.2
mvxn6
23 Aug 21
Other Events
4:43pm
8-K
EX-99.1
81cfm k2e9
5 Aug 21
Lumos Pharma Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
4:27pm